Phase 1/2 Study of Motolimod, Doxorubicin, and Durvalumab in Recurrent, Platinum-Resistant Ovarian Cancer
Clinical trial NCT02431559 · COMPLETED
Trial details
- NCT number
- NCT02431559
- Sponsor
- Ludwig Institute for Cancer Research
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-02
- Primary completion
- 2018-12-11
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.